… immune response.” What does your current role, Chief Innovation Officer, entail? “My responsibility is the … to (our CEO) Daniel that he wants to invest so much in innovation. About one third of the company is dedicated to …
There are currently around 160 people working at ProQR, but that wasn’t always the case. When Hee Lam Chan joined in 2013, she was only employee number six. As a result, she has seen the company grow and develop.
… technology development. ProQR’s Sr. Vice President Innovation makes his point about the promise of Axiomer® … to become therapeutics. Gerard Platenburg, our Chief Innovation Officer, and myself believed we could pull off …
… of our collaboration with Lilly. Lilly is a leader in innovative RNA science, making them a great partner for our … developing the medicines of tomorrow takes time, sustained innovation and most importantly, collaboration. Andrew C. …
ProQR has announced the completion of an in-depth strategic review designed to deliver on our commitment to advance RNA therapies for diseases with high unmet need. We are also sharing additional analyses of the sepofarsen Illuminate trial.
